A big drugmaker is backing away from a plan to triple the price of a lifesaving cancer drug after facing a public backlash
Thomson Reuters Drugmaker Pharmacyclics had tripled the cost of a lifesaving cancer blood treatment when it introduced a new version of the pill. The new price tag faced criticism from cance.....»»